Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (286)
Cancellation by sponsor (126)
Prescription medicine registration (12)
Australian Public Assessment Report (AusPAR) (6)
Prescription medicine decision summary (2)

Date

2024 (46)
2023 (45)
2022 (29)
2021 (13)
2020 (31)
2019 (59)
2018 (17)
2017 (14)
2016 (18)
2015 (23)
2014 (8)
2013 (26)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (13)
2006 (26)
2002 (2)
2001 (3)
1994 (7)
1992 (3)
1991 (7)

Results for "[search-keyword]"

Search

Sponsor content

432 result(s) found, displaying 21 to 30

PARACETAMOL KABI paracetamol 500mg/50mL solution for injection in freeflex bag Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESOFOL 1% MCT/LCT propofol 500mg/50mL emulsion for intravenous injection/infusion pre-filled syringe Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
FRESOFOL 1% MCT/LCT propofol 200mg/20mL emulsion for intravenous injection/infusion vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
EPIRUBICIN KABI epirubicin hydrochloride 200 mg/100 mL solution for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
CARBOPLATIN KABI carboplatin 450mg/45mL injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GEMCITABINE KABI gemcitabine (as hydrochloride) 1000 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
OXALIPLATIN KABI oxaliplatin 100mg / 20mL injection concentrated vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
PACLITAXEL KABI paclitaxel 100 mg/16.7 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
WATER FOR INJECTIONS FREEFLEX 100mL injection bag Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GLUCOSE 5% FREEFLEX glucose 2.5g/50mL injection bag Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.